WHO Pauses Hydroxychloroquine Trial Amid Safety Concerns Day After Trump Says He Stopped Taking Controversial Medicine

https://www.newsweek.com/who-pauses-hydroxychloroquine-trial-amid-safety-concerns-day-after-donald-trump-says-he-stopped-1506366

The World Health Organization announced Monday that it was pausing an ongoing trial of how hydroxychloroquine impacts hospitalized COVID-19 patients over safety concerns of the anti-malaria drug—medicine that President Donald Trump said he was taking for at least two weeks.
A "temporary pause" of the WHO's hydroxychloroquine trial was instituted while "safety data is reviewed," said WHO Director General Tedros Adhanom Ghebreyesus.

 

The trial halt comes the day after Trump revealed in an interview with Sinclair Broadcasting that he was no longer taking the unproven coronavirus treatment and prevention method that health experts and officials—including within the Trump administration—have warned not to take outside hospital or clinical trial settings because of its potentially deadly side effects.